National Peroxide Limited Reports Mixed Financial Performance for Q4 FY26

2 min read     Updated on 01 May 2026, 10:22 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

National Peroxide Limited reported contrasting financial performance for Q4 FY26, with quarterly revenue of ₹8,568.29 lakhs and profit of ₹792.86 lakhs, while annual results showed revenue decline to ₹7,370.44 lakhs and net loss of ₹649.01 lakhs. Despite annual losses, the board recommended a final dividend of ₹7 per equity share. The results were approved by the board on April 30, 2026, following regulatory compliance requirements.

powered bylight_fuzz_icon
39199934

*this image is generated using AI for illustrative purposes only.

National Peroxide Limited (formerly known as NPL Chemicals Limited) has released its audited financial results for the quarter and year ended March 31, 2026, presenting a mixed performance picture with strong quarterly results overshadowed by annual losses.

Financial Performance Overview

The company's financial performance showed significant variance between quarterly and annual results for the period ended March 31, 2026.

Metric Q4 FY26 Q4 FY25 FY26 FY25
Total Revenue from Operations ₹8,568.29 lakhs ₹6,908.70 lakhs ₹7,370.44 lakhs ₹28,971.14 lakhs
Net Profit Before Tax ₹1,065.91 lakhs ₹236.18 lakhs ₹(781.63) lakhs ₹1,501.34 lakhs
Net Profit After Tax ₹792.86 lakhs ₹183.23 lakhs ₹(649.01) lakhs ₹1,103.71 lakhs
Total Comprehensive Income ₹898.33 lakhs ₹251.01 lakhs ₹(682.39) lakhs ₹1,275.25 lakhs

Quarterly vs Annual Performance Analysis

The fourth quarter of FY26 demonstrated robust performance with revenue increasing to ₹8,568.29 lakhs compared to ₹6,908.70 lakhs in the corresponding quarter of the previous year. The quarterly net profit after tax reached ₹792.86 lakhs, showing substantial improvement from ₹183.23 lakhs in Q4 FY25.

However, the annual performance painted a contrasting picture. Full-year revenue declined significantly to ₹7,370.44 lakhs from ₹28,971.14 lakhs in the previous year. The company reported an annual net loss of ₹649.01 lakhs compared to a profit of ₹1,103.71 lakhs in FY25.

Earnings Per Share and Capital Structure

The company's earnings per share reflected the mixed performance across different periods:

Period Basic EPS (₹) Diluted EPS (₹)
Q4 FY26 13.80 13.80
Q4 FY25 3.19 3.19
FY26 (11.29) (11.29)
FY25 19.20 19.20

The paid-up equity share capital remained stable at ₹574.70 lakhs with a face value of ₹10 per share. Reserves stood at ₹35,627.05 lakhs as shown in the previous year's audited balance sheet.

Board Decisions and Dividend Declaration

Despite the annual losses, the board of directors recommended a final dividend for FY26 at 70% of the face value, equivalent to ₹7 per equity share of ₹10 each. This dividend recommendation demonstrates the board's confidence in the company's underlying business fundamentals and cash position.

The financial results underwent thorough review by the audit committee and received approval from the board of directors in their respective meetings held on April 29, 2026, and April 30, 2026.

Regulatory Compliance and Transparency

The results comply with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Complete detailed financial results are available on the stock exchange website at www.bseindia.com and the company's website at www.naperol.com , ensuring transparency for stakeholders and investors.

Historical Stock Returns for NPL

1 Day5 Days1 Month6 Months1 Year5 Years
+5.18%+10.87%+24.86%-22.51%-21.74%-49.69%

What strategic initiatives will National Peroxide implement to sustain the strong Q4 momentum throughout FY27?

How will the company fund the ₹7 per share dividend payment given the annual net loss of ₹649.01 lakhs?

What factors caused the dramatic 75% decline in annual revenue from ₹28,971 lakhs to ₹7,370 lakhs?

National Peroxide Limited Submits SEBI Compliance Certificate for Q4 FY26

1 min read     Updated on 09 Apr 2026, 08:50 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

National Peroxide Limited filed its quarterly SEBI compliance certificate for Q4 FY26 on April 09, 2026, confirming proper handling of dematerialised securities. The certificate from registrar MUFG Intime India validates adherence to prescribed timelines for security processing and depository procedures, demonstrating regulatory compliance under SEBI guidelines.

powered bylight_fuzz_icon
37293604

*this image is generated using AI for illustrative purposes only.

National Peroxide Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company filed the mandatory certificate on April 09, 2026, as required under Regulation 74(5) of SEBI regulations. Company Secretary and Compliance Officer Akshay Satasiya signed and submitted the documentation to BSE Limited, where the company trades under scrip code 544205.

Filing Details: Information
Quarter Ended: March 31, 2026
Filing Date: April 09, 2026
BSE Scrip Code: 544205
Signatory: Akshay Satasiya, Company Secretary

Registrar Confirmation

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the company's Registrar and Share Transfer Agent. The registrar issued the compliance certificate on April 3, 2026, confirming adherence to dematerialisation procedures.

Ashok Shetty, Sr. Vice President-Corporate Registry at MUFG Intime India, certified that all securities received from depository participants during the quarter were properly processed within prescribed timelines.

Compliance Confirmations

The certificate confirms several key compliance aspects:

  • Securities received for dematerialisation were confirmed or rejected to depositories within required timeframes
  • All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
  • Security certificates received for dematerialisation were properly mutilated and cancelled after verification
  • Depository names were substituted in the register of members as registered owners within prescribed timelines

Depository Notifications

npl also copied the filing to both major depositories - National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) - ensuring comprehensive regulatory compliance across all relevant authorities.

The company, formerly known as NPL Chemicals Limited, operates under CIN L24290MH2020PLC342890 with its registered office located at Neville House, J. N. Heredia Marg, Ballard Estate, Mumbai.

Historical Stock Returns for NPL

1 Day5 Days1 Month6 Months1 Year5 Years
+5.18%+10.87%+24.86%-22.51%-21.74%-49.69%

Will National Peroxide Limited's consistent regulatory compliance improve its ESG ratings and attract institutional investors?

How might the company's operational performance in Q1 FY2027 compare to the March 2026 quarter given current market conditions?

Could MUFG Intime India's rebranding from Link Intime signal enhanced digital services that benefit National Peroxide's shareholder management?

More News on NPL

1 Year Returns:-21.74%